Creo Medical Group annual free cash flow
2022
2023
2024
2025
Creo Medical Group Free Cash Flow (FCF) History (CREO)
Creo Medical Group reported −£20.0M in free cash flow for fiscal 2025, an increase of £2.6M from the previous fiscal year, with a free cash flow margin of −333.33%.
View full Creo Medical Group company overviewCreo Medical Group free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | −£20.0M | £2.6M | — | −333.33% |
| 2024 | 2024-12-31 | −£22.6M | £600,000 | — | −565.00% |
| 2023 | 2023-12-31 | −£23.2M | £5.0M | — | −580.00% |
| 2022 | 2022-12-31 | −£28.2M | — | — | −103.68% |
Creo Medical Group free cash flow growth trends
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Creo Medical Group source filings ↗Community posts
Creo Medical narrows operating loss as device revenue rises 45%
Creo Medical ($CREO) increased first-half revenue to £3.2 million from £2.2 million and reduced its underlying continuing operating loss to £4.9 million from £6.7 million. Underlying operating costs fell 15% to £7.9 million as the surgical- ...
